Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Satoru Sekoguchi is active.

Publication


Featured researches published by Satoru Sekoguchi.


Liver International | 2006

Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD

Tomoki Nakajima; Michihisa Moriguchi; Tatsuo Katagishi; Satoru Sekoguchi; Taichirou Nishikawa; Hidetaka Takashima; Hiroyuki Kimura; Masahito Minami; Yoshito Itoh; Keizo Kagawa; Yoichi Tani; Takeshi Okanoue

Abstract: Aims: The risk factors associated with poor prognosis of nonalcoholic fatty liver disease (NAFLD) are not fully understood. Our aim was to assess the role of progressive hepatocellular telomere shortening in the clinical course of NAFLD.


Journal of Gastroenterology and Hepatology | 2007

Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C.

Satoru Sekoguchi; Tomoki Nakajima; Michihisa Moriguchi; Masayasu Jo; Taichiro Nishikawa; Tatsuo Katagishi; Hiroyuki Kimura; Masahito Minami; Yoshito Itoh; Keizo Kagawa; Yoichi Tani; Takeshi Okanoue

Background:  In addition to the telomere shortening that occurs with cell division, oxidative stress can damage or shorten telomeres and induce a condition termed premature senescence, possibly before telomeres become critically short. We investigated the effects of cell‐cycle turnover and oxidative stress on cellular senescence in hepatitis C virus (HCV)‐related chronic liver injury.


Modern Pathology | 2004

Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma.

Tomoki Nakajima; Michihisa Moriguchi; Yasuhide Mitsumoto; Satoru Sekoguchi; Taichirou Nishikawa; Hidetaka Takashima; Tadashi Watanabe; Tatsuo Katagishi; Hiroyuki Kimura; Takeshi Okanoue; Keizo Kagawa

Centrosome duplication is controlled in a cell cycle-specific manner and occurs once every cell cycle, thereby ensuring the balanced segregation of chromosomes during the mitotic phase. Numerical or structural abnormalities can arise in the centrosomes of malignant cells. Under defective cell cycle checkpoint systems, cancer cells with abnormal centrosomes can survive and re-enter the cell cycle, promoting unbalanced chromosome segregation and genetic instability. We investigated the centrosome aberrations in 33 patients diagnosed with hepatocellular carcinoma (HCC), using fluorescent pericentrin immunostaining. We also studied the p53 mutation, proliferative activity, and DNA ploidy in these cases. In normal hepatocytes, one centrosome was identified per cell as a round dot, usually in the vicinity of the nuclear membrane. However, in cancer cells from HCC tissue, several patterns of centrosome abnormalities occurred, including supernumerary centrosomes and centrosomes with an abnormal shape and size. Although the frequency of abnormal centrosomes in each tissue was relatively low compared with previous reports in other cancers, nevertheless, centrosome aberration was found in 30 out of 33 HCC tissues. The percentage of tumor cells with abnormal centrosomes was significantly higher in the nondiploid tumors (15.8±15.9‰) than in the diploid tumors (5.4±5.1‰) (P<0.05), and tended to be higher in the tumors with p53 mutation (11.6±13.1‰) than in those with wild-type p53 (5.6±6.8‰). Furthermore, 82% of nondiploid tumors exhibited p53 mutation, whereas only 41% of diploid tumors showed p53 mutation. The percentage of tumor cells with centrosome abnormalities were not related to tumor stage, size or proliferative activity. Therefore, our results indicate that hepatic cancer cells, under centrosome aberration and a defective checkpoint system possibly caused by p53 mutation, have the potential for genetic instability and aggressive behavior. This potential effect occurs irrespective of the tumor size or stage.


Liver International | 2005

In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.

Hidetaka Takashima; Tomoki Nakajima; Michihisa Moriguchi; Satoru Sekoguchi; Taichiroh Nishikawa; Tadashi Watanabe; Tatsuo Katagishi; Hiroyuki Kimura; Masahito Minami; Yoshito Itoh; Keizo Kagawa; Takeshi Okanoue

Abstract: Aim: Our aim was to clarify the significance of expression levels and post‐transcriptional splicing patterns of survivin during multistep hepatocarcinogenesis and tumor progression.


Genes, Chromosomes and Cancer | 2002

Differentiation of follicular from mucosa-associated lymphoid tissue lymphoma by detection of t(14;18) on single-cell preparations and paraffin-embedded sections.

Kenichi Nomura; Satoru Sekoguchi; Kyoji Ueda; Mitsushige Nakao; Yumiko Akano; Yasuko Fujita; Yasuhide Yamashita; Shigeo Horiike; Kazuhiro Nishida; Shigeo Nakamura; Masafumi Taniwaki

A 57‐year‐old woman was referred to the Kyoto Prefectural University of Medicine because of multiple polypoid lesions in the duodenum. On the basis of the histopathologic findings, mucosa‐associated lymphoid tissue lymphoma had been diagnosed. The polypoid lesions did not show any improvement in spite of antimicrobial therapy for elimination of Helicobacter pylori. Because the disease remained stable during the clinical course, no other specific treatment was administered. We performed fluorescence in situ hybridization (FISH) analysis on a single‐cell preparation obtained from the duodenal lesions, to assess the specific chromosome translocation. We identified BCL2/IGH fusion at a frequency of 83%. Two‐color FISH was also performed on paraffin‐embedded tissue sections, which demonstrated BCL2/IGH fusion–positive cells in neoplastic follicles. These findings, together with the CD10+ immunophenotyping of tumor cells, led to a diagnosis of primary follicular lymphoma of the duodenum. Interphase FISH with the IGH gene and oncogene probes is a rapid and powerful tool for assessing genomic changes in gastrointestinal lymphoma on single‐cell preparations and tissue sections. This technique is particularly useful in view of the increasingly small core biopsy samples and needle aspirations obtained for diagnostic purposes.


Journal of Hepatology | 2006

A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins

Taichirou Nishikawa; Toshikazu Nakajima; Michihisa Moriguchi; Masayasu Jo; Satoru Sekoguchi; M. Ishii; Hidetaka Takashima; Tatsuo Katagishi; Hiroyuki Kimura; Masahito Minami; Yoshito Itoh; Keizo Kagawa; Takeshi Okanoue


Internal Medicine | 2009

Perivascular Epithelioid Cell Tumor (PEComa) of the Liver Diagnosed by Contrast-enhanced Ultrasonography

Reiko Akitake; Hiroyuki Kimura; Satoru Sekoguchi; Hideki Nakamura; Hiroshi Seno; Tsutomu Chiba; Sotaro Fujimoto


Biochemical and Biophysical Research Communications | 2004

Tumor size-independence of telomere length indicates an aggressive feature of HCC.

Tomoki Nakajima; Tatsuo Katagishi; Michihisa Moriguchi; Satoru Sekoguchi; Taichirou Nishikawa; Hidetaka Takashima; Tadashi Watanabe; Hiroyuki Kimura; Masahito Minami; Yoshito Itoh; Keizo Kagawa; Takeshi Okanoue


World Journal of Gastroenterology | 2005

Multifocal intraportal invasion of breast carcinoma diagnosed by laparoscopy-assisted liver biopsy

Tomoki Nakajima; Satoru Sekoguchi; Taichirou Nishikawa; Hidetaka Takashima; Tadashi Watanabe; Masahito Minami; Yoshito Itoh; Naruhiko Mizuta; Hiroo Nakajima; Takeshi Mazaki; Akio Yanagisawa; Takeshi Okanoue


Kanzo | 2016

A case of hepatic anisakiasis

Satoru Sekoguchi; Yasuyuki Nagao; Keisuke Takemura; Katsutoshi Yamaguchi; Katsuyuki Dainaka; Nobuhisa Yamada; Yasutaka Morimoto; Yutaka Isozaki; Hirokazu Oyamada; Hiromichi Ishii; Kenji Kawabata; Yasuko Fujita; Minoru Yamada

Collaboration


Dive into the Satoru Sekoguchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takeshi Okanoue

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hidetaka Takashima

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Keizo Kagawa

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar

Masahito Minami

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Michihisa Moriguchi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Tatsuo Katagishi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Tomoki Nakajima

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yoshito Itoh

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Taichirou Nishikawa

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge